#zepbound

[ follow ]
#eli-lilly
from24/7 Wall St.
1 week ago
Business

Is Eli Lilly Going To $1,100?

Eli Lilly delivered strong Q1 2026 results driven by Mounjaro and Zepbound, supporting a $1,164.85 price target and bullish outlook despite pricing risks.
fromFast Company
9 months ago
Healthcare

Eli Lilly is giving Novo Nordisk a run for its money-so why is LLY stock still down today?

Eli Lilly's weight-loss drugs Mounjaro and Zepbound achieved significant sales growth, bolstering the company's market share to 57%.
Despite strong earnings and drug efficacy, Eli Lilly's stock fell sharply due to higher investor expectations.
Business
from24/7 Wall St.
1 week ago

Is Eli Lilly Going To $1,100?

Eli Lilly delivered strong Q1 2026 results driven by Mounjaro and Zepbound, supporting a $1,164.85 price target and bullish outlook despite pricing risks.
Medicine
from24/7 Wall St.
5 months ago

Did Eli Lilly Just Find the Holy Grail of Weight Loss?

Eli Lilly leads weight-loss GLP-1 treatments and seeks FDA approval for orforglipron, a once-daily oral GLP-1 pill.
fromLos Angeles Times
5 months ago

Eli Lilly slashes obesity drug price by up to 20%

Starting Monday, the lowest dose vial will cost $299 a month for those who pay cash, Lilly said in a statement, a discount of about $50. The next higher dose will cost $399 a month, roughly 20% less than the previous self-pay price. Lilly isn't changing the price of higher doses, which are sold for $499 a month. It's the latest move in a price war with Denmark's Novo Nordisk, which is making it significantly less expensive for people to start the blockbuster medicines.
Healthcare
Fashion & style
fromBustle
6 months ago

Inside The Zepbound Exhibit That's Rewriting The Story Of Obesity

An immersive exhibit connects fashion narratives and personal stories to confront obesity stigma and illustrate how medications like Zepbound relate to lived experiences.
US politics
fromwww.mediaite.com
6 months ago

TrumpRX.com Crashes Within Minutes of Trump Telling Staff to Make Sure It Works

TrumpRx.com, promoted as a portal for discounted weight-loss drugs, went offline minutes after President Trump announced it.
[ Load more ]